Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411014 | SCV000489015 | likely benign | Colorectal cancer, susceptibility to, 12 | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000435321 | SCV000519164 | likely benign | not specified | 2017-06-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000435321 | SCV000806717 | benign | not specified | 2016-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003114529 | SCV001733464 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488844 | SCV002797339 | likely benign | Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | 2022-05-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003114529 | SCV003799392 | benign | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000411014 | SCV004016711 | likely benign | Colorectal cancer, susceptibility to, 12 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000435321 | SCV004027365 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing |